Lehrer RI, Ganz T. Defensins of vertebrate animals. Curr Opin Immunol 2002; 14(1): 96-102.

Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature 1997;387(6636):861.

Chertov O, Yang D, Howard OM, Oppenheim JJ. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev 2000;177:68-78. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002;298(5595): 1025-9.

Pangburn MK, Pangburn KL, Koistinen V, Meri S, Sharma AK. Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement. J Immunol 2000; 164(9) :4742-51.

Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol 2002;20:825-52.

Sims JE. IL-1 and IL-18 receptors, and their extended family. Curr Opin Immunol 2002;14(1):117-22.

Silva FRMB, Leite LD, Wassermann GF. Rapid signal transduction in Sertoli cells. Eur J Endocrinology 2002;147:425-33.

Jonsson CK, Zetterström RH, Holst M, Parvinen M, Söder O. Constitutive expression of interleukin-la messenger riboneucleic acid in rat Sertoli cells is dependent upon interaction with germ cells. Endocrinology 1999;140:3755-61.

90. Ulrichs T, Porcelli SA. CD1 proteins: targets of T cell recognition in innate and adaptive immunity. Rev Immunogenet 2000;2(3):416-32.

91. Matsukawa A, Hogaboam CM, Lukacs NW, Kunkel SL. Chemokines and innate immunity. Rev Immunogenet 2000;2(3):339-58.

92. Luster AD. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 2002; 14(1): 129-35.

93. Dalpiaz A, Spisani S, Biondi C, Fabbri E, Nalli M, Ferretti ME. Studies on human neutrophil biological functions by means of formyl-peptide receptor agonists and antagonists. Curr Drug Targets Immune Endocr Metabol Disord 2003;3(l):33-42.

94. Moretta L, Bottino C, Pende D, Mingari MC, Biassoni R, Moretta A. Human natural killer cells: their origin, receptors and function. Eur J Immunol 2002;32(5): 1205-11.

95. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999;17:875-904.

96. Kelm S, Schauer R. Sialic acids in molecular and cellular interactions. Int Rev Cytol 1997;175:137-240.

97. Pilatte Y, Bignon J, Lambre CR. Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity. Glycobiology 1993;3(3):201-18.

98. Crocker PR, Varki A. Siglecs in the immune system. Immunology 2001; 103(2): 137^-5.

99. Angata T, Varki A. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways. J Biol Chem 2000;275(29):22127-35.

100. Sonnenburg JL, Altheide TK, Varki A. A uniquely human consequence of domain-specific functional adaptation in sialic acid-binding receptor. Glycobiology 2003 ;Dec 23 (Epub ahead of print)

101. Lemke G, Lu Q. Macrophage regulation by Tyro 3 family receptors. Curr Opin Immunol 2003;15(l):31-6.

102. Tough DF, Chow DA. Natural antibody recognition of v-H-ras induced IOTV2 transformation. Natural Immun Cell Growth Regul 1991;10:83-93.

103. Tough DF, Haliotis T, Chow DA. Regulation of natural antibody binding and susceptibility to natural killer cells through Zn++-inducible ras oncogene expression. Int J Cancer 1992;50:423-30.

104 Tough DF, Feng X, Chow DA. p21ms independent down-regulation of ras-induced increases in natural antibody binding during tumor progression. Nat Immun 1995;14:20-34.

105. Wang H, Chow DA. PKC expression in IOTV2 cells associated increased acquisition of natural antibodies with surveillance of preneoplasia and homeostasis of the organism. Scand J Immunol 1999;49(4):381-90.

106. Chow DA, Wolosin LB, Greenberg AH. Murine natural antitumor antibodies II. The contribution of natural antibodies to tumor surveillance. Int J Cancer 1981 ;27:459-69.

107. Chow DA. Reduced tumorigenicity of threshold tumor inocula in xid-bearing mice treated with natural antibodies. Int J Cancer 1995;60:848-53.

108. Chow DA, Yuan X-y, Tough DF. Polyclonal natural antitumor antibody binding dynamics: Preferential release of surface membrane molecules and increased metastasis. Inv & Met 1992;12:218-32.

109. Zhang Z, Chow DA. Differential CD45 isoform expression accompanies reduced natural antibody binding in L5178Y-F9 tumor progression. J Immunol 1997;159(l):44-50.

110. Deans JP, Serra HM, Shaw J, Shen YJ, Torres RM, Pilarski LM. Transient accumulation and subsequent rapid loss of messenger RNA encoding high molecular mass CD45 isoforms after T cell activation. J Immunol 1992;148:1898-1905.

111. Johannisson A, Festin R. Phenotype transition of CD4+ T cells from CD45RA to CD45RO is accompanied by cell activation and proliferation. Cytometry 1995;19:343-52.

112. Yamada A, Streuli M, Saito H, Rothstein DM, Schlossman SF, Morimoto C. Effect of activation of protein kinase C on CD45 isoform expression and CD45 protein tyrosine phosphatase activity in T cells. Eur J Immunol 1990;20:1655-60.

113. Bohn J, Roggenbuck D, Settmacher U, Docke W, Volk HD, Von-Baehr R, Jahn S. Binding of natural human IgM auto-antibodies to human tumor cell lines and stimulated normal T lymphocytes. Immunol Lett 1994;39:187-94.

114. Wolf-Levine R, Azuma T, Aoki K, Yagami Y, Okada H. Specific IgG autoantibodies are potent inhibitors of autoreactive T cells. J Immunol 1993;151:5864-77.

115. Landolfi NF, Leone J, Womack JE, Cook RG. Activation of T lymphocytes results in an increase in H-2-encoded neuraminidase. Immunogenetics 1985;22:159-67.

116. Karnitz LM, Abraham RT. Interleukin-2 receptor signaling mechanisms. Adv Immunol 1996;61:147-99.

117. Koopman , Heider K-H, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993; 177: 897-904.

118. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zoller M. Participation in normal immune responses of a metastasis inducing splice variant of CD44. Science 1992;257:682-5.

119. Galluzzo E, Albi N, Fiorucci S, Merigiola C, Ruggeri L, Tosti A, Grossi CE, Velardi A. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur J Immunol 1995;25:2932-9.

120. Chow DA, Li Y, Hebert S. Natural human antibody and intravenous immunolglobulin regulation of T cell activation. Cancer Detec Prev 2002;S 176.

121. Xu Z, Weiss A. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat Immunol 2002;3(8):764-71.

122. Greenberg S, Grinstein S. Phagocytosis and innate immunity. Curr Opin Immunol 2002; 14(1): 136-45.

123. Franc NC. Phagocytosis of apoptotic cells in mammals, Caenorhabditis elegans and Drosophila melanogaster: molecular mechanisms and physiological consequences. Frontiers in Bioscience 2002;7:dl298-1313.

124. Rescigno M, Granucci F, Ricciardi-Castagnoli P. Dendritic cells at the end of the millennium. Immunol Cell Biol 1999;77(5):404-10.

125. Engering A, Geijtenbeek TB, van Vliet SJ, Wijers M, van Liempt E, Demaurex N, et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 2002; 168(5):2118-26.

126. Granucci F, Zanoni I, Feau S, Ricciardi-Castagnoli P. Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. Embo J 2003;22(11 ):2546-51.

127. Ley K. Integration of inflammatory signals by rolling neutrophils. Immunol Rev 2002; 186: 8-18.

128. Malaviya R, Gao Z, Thankavel K, van der Merwe PA, Abraham SN. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sei U S A 1999;96(14):8110-5.

129. Malaviya R, Ross EA, MacGregor JI, Ikeda T, Little JR, Jakschik BA, et al. Mast cell phagocytosis of FimH-expressing enterobacteria. J Immunol 1994; 152(4): 1907-14.

130. Supajatura V, Ushio H, Nakao A, Akira S, Okumura K, Ra C, et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 2002; 109(10): 1351-9.

131. Wedemeyer J, Tsai M, Galli SJ. Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 2000;12(6):624-31.

132. Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Gastrointestinal eosinophils. Immunol Rev 2001;179:139-55.

133. Kazmierczak BI, Mostov K, Engel JN. Interaction of bacterial pathogens with polarized epithelium. Annu Rev Microbiol 2001 ;55:407-35.

134. Kagnoff MF, Eckmann L. Epithelial cells as sensors for microbial infection. J Clin Invest 1997; 100(1 ):6—10.

135. Hauck CR, Meyer TF. 'Small' talk: Opa proteins as mediators of Neisseria-host-cell communication. Curr Opin Microbiol 2003;6(l):43-9.

136. Cossart P, Pizarro-Cerda J, Lecuit M. Invasion of mammalian cells by Listeria monocytogenes: functional mimicry to subvert cellular functions. Trends Cell Biol 2003; 13(1 ):23-31.

137. Cario E, Gerken G, Podolsky DK. "For whom the bell tolls!" — innate defense mechanisms and survival strategies of the intestinal epithelium against lumenal pathogens. Z Gastroenterol 2002;40(12):983-90.

138. Martin F, Kearney JF. Bl cells: similarities and differences with other B cell subsets. Curr Opin Immunol 2001; 13(2): 195-201.

139. Koide N, Sugiyama T, Kato Y, Chakravortty D, Mu MM, Yoshida T, et al. Mouse Bl cell line responds to lipopolysaccharide via membrane-bound CD 14. J Endotoxin Res 2001;7(1):39^13.

140. Kaplan D, Smith D, Meyerson H, Pecora N, Lewandowska K. CD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation. Proc Natl Acad Sei U S A 2001 ;98(24): 13850-3.

141. Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol 1993;11:501-38.

142. Allison JP, Havran WL. The immunobiology of T cells with invariant y8 antigen receptors. Annu Rev Immunol 1991;9:679-705.

143. McVay LD, Carding SR. Generation of human gammadelta T-cell repertoires. Crit Rev Immunol 1999; 19 (5-6):431-60.

144. Carding SR, Egan PJ. Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002;2(5):336^15.

145. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today. 2000;21(11):573-83.

146. Stout RD, Schwarting GA, Suttles J. Evidence that expression of asialo-GMl may be associated with cell activation. Correlation of asialo-GMl expression with increased total cellular RNA and protein content in normal thymocyte and spleen cell populations. J Immunol 1977; 139(7):2123-9.

147. Quinn MT, Swain SD, Parkos CA, Jutila KL, Siemsen DW, Kurk SL, et al. A carbohydrate neoepitope that is up-regulated on human mononuclear leucocytes by neuraminidase treatment or by cellular activation. Immunology 2001; 104(2): 185-97. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. PNAS 2000;97:13766-71.

Natural Immunity

Edited by L. Bertök and D.A. Chow © 2005 Elsevier B.V. All rights reserved

How To Bolster Your Immune System

How To Bolster Your Immune System

All Natural Immune Boosters Proven To Fight Infection, Disease And More. Discover A Natural, Safe Effective Way To Boost Your Immune System Using Ingredients From Your Kitchen Cupboard. The only common sense, no holds barred guide to hit the market today no gimmicks, no pills, just old fashioned common sense remedies to cure colds, influenza, viral infections and more.

Get My Free Audio Book

Post a comment